Top Page
Craneware
(LSE:CRW)
Craneware (CRW) vs. iShares MSCI United Kingdom ETF (EWC)
Craneware Business Overview & Revenue Model
Craneware Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 198.10M | 205.66M | 174.02M | 189.27M | 165.54M | 75.58M |
| Gross Profit | 171.02M | 179.27M | 148.44M | 162.20M | 142.37M | 70.20M |
| EBITDA | 36.65M | 38.80M | 51.60M | 54.26M | 47.54M | 18.48M |
| Net Income | 14.88M | 19.66M | 9.23M | 11.70M | 9.41M | 12.90M |
Balance Sheet | ||||||
| Total Assets | 565.96M | 551.06M | 576.98M | 543.65M | 568.79M | 311.60M |
| Cash, Cash Equivalents and Short-Term Investments | 72.16M | 55.92M | 78.54M | 34.59M | 47.16M | 235.62M |
| Total Debt | 35.89M | 31.65M | 86.69M | 40.15M | 115.52M | 2.20M |
| Total Liabilities | 236.84M | 213.50M | 249.13M | 215.06M | 235.77M | 51.32M |
| Stockholders Equity | 329.12M | 337.56M | 327.84M | 328.59M | 333.02M | 260.28M |
Cash Flow | ||||||
| Free Cash Flow | 68.61M | 59.41M | 83.20M | 24.91M | 12.93M | 13.21M |
| Operating Cash Flow | 69.53M | 59.90M | 98.75M | 41.86M | 26.96M | 23.54M |
| Investing Cash Flow | -14.27M | -13.98M | -15.34M | -15.81M | -307.32M | -10.32M |
| Financing Cash Flow | -46.99M | -24.58M | -53.28M | -70.00M | 91.90M | 174.55M |
Craneware Technical Analysis
Craneware Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | £816.46M | 53.67 | 6.00% | 1.27% | 5.74% | 62.18% | |
| ― | £471.27M | 51.29 | 3.66% | 1.23% | 68.03% | -18.27% | |
| ― | £953.62M | 51.52 | 2.51% | 0.97% | 6.95% | -34.38% | |
| ― | £324.82M | 9.41 | 15.04% | ― | 1231.50% | ― | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | £1.36B | ― | -26.01% | ― | 22.03% | 20.01% |
Craneware Corporate Events
Craneware plc has announced the posting of its Annual Report and Accounts for the year ending 30 June 2025, along with the Notice of Annual General Meeting (AGM) scheduled for 21 November 2025. David Kemp, the Senior Non-Executive Director and Chair of the Audit Committee, will retire from the Board on the day of the AGM, after nearly six years of service. The Board expressed gratitude for his contributions and will update on the recruitment of a new Independent Non-Executive Director.
The most recent analyst rating on (GB:CRW) stock is a Hold with a £2473.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Craneware plc has updated its issued share capital following recent employee share option exercises, resulting in 35,431,867 Ordinary Shares with voting rights. This change in share capital is significant for shareholders as it affects calculations related to their interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:CRW) stock is a Hold with a £2473.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Craneware plc announced the grant of conditional share awards under its Long Term Incentive Plan (2022) to key executives, including the CEO, CFO, CPO, and CLO. These awards are contingent on performance conditions related to shareholder return and earnings growth over a five-year period, with a two-year holding period post-vesting, reflecting the company’s commitment to aligning executive incentives with long-term shareholder value.
The most recent analyst rating on (GB:CRW) stock is a Buy with a £2492.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Craneware plc reported strong financial results for FY25, with a 9% increase in revenue to $205.7 million and a 12% rise in adjusted EBITDA to $65.3 million. The company achieved significant growth in statutory profit before tax, up 52%, and improved customer retention rates, reflecting its strategic position in the US healthcare market. Craneware’s continued investment in R&D, successful integration of customer-facing teams, and alliance with Microsoft have reinforced its market leadership. The launch of AI-powered solutions and the transition of Trisus Platform revenues to recurring revenues are expected to drive further growth. The company’s outlook remains positive, with confidence in continued growth acceleration in FY26.
The most recent analyst rating on (GB:CRW) stock is a Buy with a £2492.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Craneware plc has successfully refinanced its banking facilities, enhancing its financial flexibility to support growth strategies. The new $100 million unsecured Revolving Credit Facility (RCF) offers improved terms and lower interest rates, consolidating previous loans and providing an additional $100 million accordion facility for potential mergers and acquisitions. This move, along with a proposed capital reduction to increase distributable reserves, positions Craneware to deliver shareholder returns and sustain its strong market position. The company reported positive trading results for the fiscal year ending June 2025, with increased revenue, profitability, and reduced debt, underscoring its robust financial health and strategic focus on growth in the U.S. healthcare market.
The most recent analyst rating on (GB:CRW) stock is a Buy with a £2492.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Craneware plc announced the successful approval of resolutions at its General Meeting to reduce capital, which was supported by shareholders. This capital reduction, pending court approval, is part of Craneware’s strategic financial management to optimize its resources and enhance its market position. The move is expected to strengthen the company’s financial reserves, potentially benefiting stakeholders by improving financial flexibility and supporting future growth initiatives.
The most recent analyst rating on (GB:CRW) stock is a Buy with a £2492.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Craneware plc announced that shareholders approved resolutions for a proposed capital reduction at a recent general meeting. The capital reduction, which requires court confirmation, involves capitalizing the merger reserve, allotting and canceling B ordinary shares, and crediting the reductions to company reserves. This move is expected to streamline the company’s financial structure and enhance operational efficiency, potentially impacting stakeholders positively by optimizing financial resources.
The most recent analyst rating on (GB:CRW) stock is a Buy with a £2492.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Craneware plc has announced a proposed reduction of capital, which involves the cancellation of its share premium account and the capitalisation of its merger reserve. This strategic move, pending shareholder and court approval, aims to create distributable reserves of approximately $284 million, providing the company with increased flexibility for shareholder returns. The reduction of capital will not affect the company’s net assets, indicating a strategic financial maneuver to enhance shareholder value without impacting the company’s operational stability.
The most recent analyst rating on (GB:CRW) stock is a Buy with a £54.50 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.